Clinical Trials Search Tool

A trial of oral Semaglutide in patients with early Alzheimer’s Disease (EVOKE)

Disease/Condition: Alzheimer’s disease

Location: Portland

Ages: 55-85

Enrollment Opens: 01-31-2022

Enrollment Closes: TBD


This is a clinical trial that is looking at the efficacy and safety of oral Semaglutide (GLP-1 agonist) versus placebo on the change in cognition and function in patients with MCI (Mild Cognitive Impairment) or mild dementia, both of the Alzheimer’s type.

Study ID: NovoNordisk NN6536-4730

To Enroll: Please call (503) 228-2273 (CARE) to schedule free memory lost testing and evaluation. Or contact for additional informaton.

Posted by: Summit Headlands LLC |